Bronchial Hyperresponsiveness

Bronchial Hyperresponsiveness (BHR) is a condition characterized by an increased sensitivity of the airways to various stimuli, leading to narrowing and obstruction of the airways. This condition is closely associated with asthma, but it can also be observed in individuals without asthma. BHR is an important feature in the diagnosis and management of respiratory diseases, particularly asthma.

Causes

The exact cause of BHR is not fully understood, but it is believed to result from a combination of genetic and environmental factors. These may include:

• Allergen exposure
• Respiratory infections
• Air pollution
• Exposure to tobacco smoke
• Occupational irritants

Pathophysiology

BHR involves complex interactions between airway inflammation, neural control mechanisms, and the physical properties of the airway wall. In susceptible individuals, exposure to certain triggers leads to:

• Inflammation and swelling of the airway lining
• Increased mucus production
• Bronchoconstriction (tightening of the muscles around the airways)

These changes result in a narrowed airway, making it difficult for air to move in and out of the lungs, and can lead to symptoms such as wheezing, coughing, shortness of breath, and chest tightness.

Diagnosis

Diagnosis of BHR involves a combination of medical history, physical examination, and specialized tests. Key diagnostic tests include:

• Spirometry: Measures the amount and speed of air that can be inhaled and exhaled, indicating obstruction in the airways.
• Bronchial challenge test: Involves inhaling increasing concentrations of a specific substance (e.g., methacholine) to provoke airway narrowing, assessing the sensitivity of the airways.

Treatment

Treatment of BHR aims to reduce sensitivity to triggers and control symptoms. This may involve:

• Avoidance of known triggers
• Use of inhaled corticosteroids to reduce inflammation
• Use of bronchodilators to relax airway muscles
• Immunotherapy in cases related to specific allergens

Prevention

Preventive measures for BHR focus on minimizing exposure to known triggers and managing underlying conditions that may contribute to airway hyperresponsiveness. Regular follow-up with a healthcare provider is essential to monitor the condition and adjust treatment as necessary.

Conclusion

Bronchial Hyperresponsiveness is a significant clinical feature in the diagnosis and management of asthma and other respiratory conditions. Understanding the causes, pathophysiology, and treatment options is crucial for effective management and improving the quality of life for individuals affected by this condition.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian